At the end of the study, the regulatory T cell response was analyzed through TGF-β and Foxp3 gene expression in the tumor microenvironment, which was reduced in both cohorts as a result of the 2 and 4 mg doses of glucomannan. Here, TGFB1 is linked to neoplasm.